Abstract
Based on the previous reports on α-glucosidase inhibitory activity of benzimidazole class, we intend to evaluate further this class as potential inhibitors of α-glucosidase enzyme. Thus, in the current study synthesis of 5-bromo-2-aryl benzimidazole derivatives 1–25 was carried out. All the synthetic compounds were characterized by different spectroscopic techniques EIMS, HRMS, 1H-NMR, and 13C-NMR. Molecular docking was also performed on the selected compounds 1, 4, 7, and 17 having varying substitution pattern in order to understand the molecular interaction of molecules with the active site of the enzyme. All compounds were evaluated for their in vitro α-glucosidase inhibitory activities. Twenty-three compounds out of twenty-five showed excellent to moderate activity in the range of IC50 = 12.4–103.2 μM. Inhibitory results were compared with the standard drug acarbose (IC50 = 38.25 ± 0.12 μM). Compounds 1 (IC50 = 37.82 ± 0.08 μM), 9 (IC50 = 37.76 ± 0.05 μM), 12 (IC50 = 24.96 ± 0.09 μM), 16 (IC50 = 21.15 ± 0.08 μM) and 17 (IC50 = 8.34 ± 0.02 μM) showed excellent inhibition as compared to standard drug acarbose (IC50 = 38.25 ± 0.12 μM). Especially, 17 (IC50 = 8.34 ± 0.02 μM) was found to be five-fold more active than the standard.
Similar content being viewed by others
References
Achar K, Hosamani KM, Seetharamareddy HR (2010) In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur J Med Chem 45:2048–2054
Ag H (1994) Pharmacology of α‐glucosidase inhibition. Eur J Clin Invest 1:3–10
Bansal Y, Silakari O (2012) The therapeutic journey of benzimidazole: a review. Bioorg Med Chem 20:6208–6236
Błaszczak-Świątkiewicz K, Olszewska P, Mikiciuk-Olasik E (2014) Biological approach of anticancer activity of new benzimidazole derivatives. Pharma Rep 66:100–106
Brink NG, Folkers K (1949) Vitamin B12. VI. 5,6-Dimethylbenzimidazole, a degradation product of vitamin B12. J Am Chem Soc 71:2951–2951
Calcul L, Longeon A, Mourabit AA, Guyot M, Bourguet-Kondracki ML (2003) Novel alkaloids of the aaptamine class from an Indonesian marine sponge of the genus Xestospongia. Tetrahedron 59:6539–6544
Castillo I, Suwalsky M, Gallardo MJ, Troncoso V, Sánchez-Eguía BN, Santiago-Osorio E, Aguiñiga I, González-Ugarte AK (2016) Structural and functional effects of benzimidazole/thioether copper complexes with antitumor activity on cell membranes and molecular models. J Inorg Biochem 156:98–104
Cui M, Ono M, Kimura H, Kawashima H, Liu BL, Saji H (2011) Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer’s disease. Nucl Med Biol 38:313–320
Dandegaonker SH, Shastri D (1965) Bromobenzimidazoles. Monatsh Chem 96:614–24
Desai NC, Shihory NR, Kotadiya GM, Desai P (2014) Synthesis, antibacterial and antitubercular activities of benzimidazole bearing substituted 2-pyridone motifs. Eur J Med Chem 82:480–489
Dinparast L, Valizadeh H, Bahadori MB, Soltani S, Asghari B, Rashidi MR (2016) Design, synthesis, α-glucosidase inhibitory activity, molecular docking and QSAR studies of benzimidazole derivatives. J Mol Struct 1114:84–94
Gallienne E, Gefflaut T, Bolte J, Lemaire M (2006) Synthesis of new nitrogen analogues of salacinol and deoxynojirimycin and their evaluation as glycosidase inhibitors. J Org Chem 71:894–902
Gao C, Li B, Zhang B, Sun Q, Li L, Li X, Chen C, Tan C, Liu H, Jiang Y (2015) Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents. Bioorg Med Chem 23:1800–1807
Gao H, Huang YN, Xu PY, Kawabata J (2007) Inhibitory effect on α-glucosidase by the fruits of Terminalia chebula Retz. Food Chem 105:628–634
Groopman JE (1990) Current advances in the diagnosis and treatment of AIDS: An introduction. Rev Infect Dis 12:908–911
Guo XZ, Shi L, Wang R, Liu XX, Li BG, Lu XX (2008) Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring. Bioorg Med Chem 16:10301–10310
Kashtoh H, Hussain S, Khan A, Saad SM, Khan JAJ, Khan KM, Perveen S, Choudhary MI (2014) Oxadiazoles and thiadiazole: Novel α-glucosidase inhibitors. Bioorg Med Chem 22:5454–5465
Kazimierczuk Z, Upcroft JA, Upcroft P, Gorska A, Starosciak B, Laudy A (2002) Synthesis, antiprotozoal and antibacterial activity of nitro and halogeno-substituted benzimidazole derivatives. Acta Biochem Pol 49:185–196. English edition
Khan KM, Rahat S, Choudhary MI, Rahman Atta-ur, Ghani U, Perveen S, Khatoon S, Dar A, Malik A (2002) Synthesis and biological screening of 2-[4-substituted phenyl] 4-(2-cyanoethyl)-4(H)-1,3,4-oxadiazine-5(6H)-ones and their intermediates. Helv Chem Acta 85:559–570
Khan M, Yousaf M, Wadood A, Junaid M, Ashraf M, Alam U, Ali M, Arshad M, Hussain Z, Khan KM (2014) Discovery of novel oxindole derivatives as potent α-glucosidase inhibitors. Bioorg Med Chem 22:3441–3448
Khan KM, Saify ZS, Begum S, Noor F, Khan MZ, Hayat S, Choudhary MI, Perveen S, Ullah Zia (2003) Synthesis and biological screening of 7-hydroxy-4-methyl-2H-chromen-2-one, 7-hydroxy-4,5-dimethyl-2H-chromen-2-one and their some derivatives. Nat Prod Res 17:115–125
Khan KM, Saify ZS, Hayat S, Khan MZ, Noor F, Choudhary MI, Ullah Zia, Perveen S (2002) Synthesis and antioxidant and insecticidal activities of coumarin derivatives. J Chem Soc Pak 24:226–231
Khan KM, Saify ZS, Khan ZA, Ahmed M, Saeed M, Abdel-Jalil RJ, Grubler G, Voelter W (1999) Syntheses of selected quaternary phenacylbromopyridinium compounds and their biological evaluation. Z Naturforsch 54b:1210–1218
Khan KM, Saify ZS, Khan ZA, Ahmed M, Saeed M, Schick M, Kohlbau HJ, Voelter W (2000) Syntheses and cytotoxic, antimicrobial, antifungal and cardiovascular activity of new quinoline derivatives. Arzneim Forsch/Drug Res 50:915–924
Khan KM, Saleem M, Perveen S, Khan M (2013) Benzimidazoles: a new class of carbonic anhydrase inhibitors. J Chem Soc Pak 35:901–904
Kumar JA, Tiwari AK, Ali AZ, Madhusudhana K, Reddy BS, Ramakrishna S, Raju BC (2010) New antihyperglycemic, α-glucosidase inhibitory, and cytotoxic derivatives of benzimidazoles. J Enzyme Inhib Med Chem 25:80–86
Lesley JS, Spencer CM (2000) Miglitol. Drugs 59:521–549
Mariappan G, Hazarika R, Alam F, Karki R, Patangia U, Nath S (2015) Synthesis and biological evaluation of 2-substituted benzimidazole derivatives. Arabian J Chem 8:715–719
Mavrova AT, Yancheva D, Anastassova N, Anichina K, Zvezdanovic J, Djordjevic A, Markovic D, Smelcerovic A (2015) Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles. Bioorg Med Chem 23:6317–6326
Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J (2000) Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care 23:1162–1167
Mobinikhaledi A, Asghari B, Jabbarpour M (2015) Design and synthesis of new benzimidazole and pyrimidine derivatives as α-glucosidase inhibitor. Iranian J Pharm Res 14:723–731
Nakano H, Inoue T, Kawasaki N, Miyataka H, Matsumoto H, Taguchi T, Inagaki N, Nagai H, Satoh T (2000) Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action. Bioorg Med Chem 8:373–380
Niaz H, Kashtoh H, Khan AJ, Khan A, Wahab Atia-tul, Alam MT, Khan KM, Perveen S, Choudhary MI (2015) Synthesis of diethyl 4-substituted-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylates as a new series of inhibitors against yeast α-glucosidase. Eur J Med Chem 95:199–209
Olbe L, Carlsson E, Lindberg P (2003) A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nat Rev Drug Disc 2:132–139
Ozden S, Atabey D, Yıldız S, Goker H (2005) Synthesis and potent antimicrobial activity of some novel methyl or ethyl-yl-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups. Bioorg Med Chem 13:1587–1597
Rahim F, Malik F, Ullah H, Wadood A, Khan F, Javid MT, Taha M, Rehman W, Rehman AshfaqUr, Khan KM (2015) Isatin based schiff bases as inhibitors of α-glucosidase: synthesis, characterization, in vitro evaluation and molecular docking studies. Bioorg Chem 60:42–48
Rahim F, Ullah K, Ullah H, Wadood A, Taha M, Rehman AshfaqUr, Uddin I, Ashraf M, Shaukat A, Rehman W, Hussain S, Khan KM (2015) Triazinoindole analogs as potent inhibitors of α-glucosidase: synthesis, biological evaluation and molecular docking studies. Bioorg Chem 58:81–87
Rhabasa-Lhoret R, Chiasson JL, Defronzo RA, Ferrannini E, Keen H, Zimmet P (2004) α-glucosidase inhibitors, International Textbook of Diabetes Mellitus, 1st edn.. John Wiley, UK
Saify ZS, Khan KM, Haider SM, Zeeshan Shah STA, Saeed M, Shekhani MS, Voelter W (1999) Syntheses and evaluation of the analgesic activity of some 4-acetyl-4- phenylepiperidine and 4-hydroxy-4-phenylepiperidine derivatives. Zeitsch Naturforsch 54b:1327–1336
Song WJ, Lin QY, Jiang WJ, Du FY, Qi QY, Wei Q (2015) Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with norcantharidin andbenzimidazole derivatives. . Spectrochim Acta Part A 137:122–128
Sur D, Saha D, Manna B, Rajendran K, Bhattacharya S (2005) Periodic deworming with albendazole and its impact on growth status and diarrhoeal incidence among children in an urban slum of India. Trans Royal Soc Tropic Med Hyg 99:261–267
Taha M, Ismail NH, Lalani S, Fatmi MQ, Wahab Atia-tul, Siddiqui S, Khan KM, Imran S, Choudhary MI (2015) Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. Eur J Med Chem 92:387–400
van de Laar FA (2008) α-Glucosidase inhibitors in the early treatment of type 2 diabetes, Vasc. Health Risk Manag 4:1189–1195
Walia R, Hedaitullah M, Naaz SF, Iqbal K, Lamba HS (2011) Benzimidazole derivatives, An overview. Int J Res Pharm Chem 1:2231–2781
Zaidi JH, Naeem F, Iqbal R, Choudhary MI, Khan KM, Shah STA, Hayat S, Voelter W (2001) Synthesis and bioactivities of naturally occurring anthraquinones: isochrysophanol, isozyganein, ω-hydroxyisochrysophanol and morindaparvin. Z Naturforsch 56b:689–696
Zawawi NKNA, Taha M, Ahmat N, Wadood A, Ismail NH, Rahim F, Ali M, Abdullah N, Khan KM (2015) Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies. Bioorg Med Chem 23:3119–3125
Zhang J, Wang JL, Zhou ZM, Li ZH, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Hua A (2012) Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1receptor antagonists. Bioorg Med Chem 20:4208–4216
Zitzmann N, Mehta AS, Carrouée S, Butters TD, Platt FM, McCauley J, Blumberg BS, Dwek RA, Block TM (1999) Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents. Proc Nat Ac Sci 96:11878–11882
Acknowledgments
The authors are thankful to the Higher Education Commission (HEC) Pakistan, for their financial support to Research Project No. 20-2073 under National Research Program for Universities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Arshad, T., Khan, K.M., Rasool, N. et al. Syntheses, in vitro evaluation and molecular docking studies of 5-bromo-2-aryl benzimidazoles as α-glucosidase inhibitors. Med Chem Res 25, 2058–2069 (2016). https://doi.org/10.1007/s00044-016-1614-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1614-y